The Best of WCLC is an educational initiative of the IASLC designed to present a multi-disciplinary and multi-specialty approach to education, engaging both community and academic practitioners unable to attend the World Conference on Lung Cancer. The “Best of” program will condense the most exciting and practice-changing data from multiple disciplines into a single-day event to optimize information transfer from the WCLC to busy healthcare professionals, with a focus on the most important advances in the care of patients with thoracic malignancies.
The program is designed to increase attendee competency in the latest developments in the field, translating into improved practice patterns. Together with IASLC, local faculty will pick from multi-disciplinary topics to select materials of most interest to local attendees. Presentations will be followed by an interactive panel discussion so that participants will be able to ask questions and receive immediate feedback from a multi-disciplinary panel, as appropriate for the topic. Example of topics to be included are information on advances in CT screening for lung cancer, diagnosis and staging, surgery and radiotherapy, chemotherapy, targeted therapy and immunotherapy, as well as highlighting results of recent clinical trials.
Date Oct 05, 2024
Location Hotel Nikko San Francisco, San Francisco, CA
The Best of WCLC 2024 San Francisco is designed for:
- Medical Oncologists: Specialists in cancer treatment, particularly lung cancer.
- Thoracic Surgeons: Professionals focusing on surgical interventions for thoracic malignancies.
- Radiation Oncologists: Experts in radiotherapy for lung cancer.
- Radiologists and Pathologists: Those involved in imaging and diagnostic processes.
- Advanced Practice Nurses and Physician Assistants: Healthcare providers supporting lung cancer care.
This event condenses key findings from the World Conference on Lung Cancer into a single-day program, offering multidisciplinary insights and interactive discussions.
+ Topics:
Adjuvant-Neo-adjuvant Systemic Therapy.mp4
ALK, ROS1, and BRAF Positive Lung Cancer.mp4
EGFR Mutated Lung Cancer – Advanced Stage.mp4
Locally Advanced NSCLC Chemotherapy – Targeted Therapy – Immunotherapy.mp4
Locally Advanced NSCLC- Radiation Therapy.mp4
Lung Cancer Screening – Tobacco Control.mp4
Mesothelioma and Thymoma – Limited and Advanced Stage.mp4
Other Immunotherapy Targets & Agents- Advanced NSCLC.mp4
Palliative Care Approaches in Lung Cancer.mp4
PD-1-PD-L1 Directed Immunotherapy for Advanced NSCLC.mp4
Pulmonary – From Diagnostics to Therapeutics.mp4
Radiation in Early-Stage NSCLC.mp4
Small Cell Lung Cancer.mp4
Stage III NSCLC – Surgical-Combined Modality.mp4
Surgery for Early-Stage NSCLC.mp4
Tumor Biology, Pathology, Novel Diagnostics.mp4